PETV | PetVivo Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5825 - 0.5950
52 Week Range	0.2900 - 2.1900
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	6,100
Average Volume	22,835
Shares Outstanding	20,004,900
Market Cap	11,652,854
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2014-09-08

Valuation
Profitability
Growth
Health
P/E Ratio	-0.91
Forward P/E Ratio	N/A
EPS	-0.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	20
Country	USA
Website	PETV

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PETV's peers: MODD, BTCY, ECOR, EYEG, ICCM, IRIX, LOGC, NMTC, NSYS, NVNO

*Chart delayed

Analyzing fundamentals for PETV we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see PETV Fundamentals page.

Watching at PETV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PETV Technicals page.